Cargando…
Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities
It is well‐recognized that therapeutic proteins (TPs) with pro‐inflammatory activities elevate the pro‐inflammatory cytokines and result in cytokine‐drug interactions. In the current review, several pro‐inflammatory cytokines, including IL‐2, IL‐6, IFN‐γ, and TNF‐α, as well as an anti‐inflammatory c...
Autores principales: | Yu, Yanke, Henrich, Charity, Wang, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264930/ https://www.ncbi.nlm.nih.gov/pubmed/36890677 http://dx.doi.org/10.1111/cts.13507 |
Ejemplares similares
-
Considerations and recommendations for assessment of plasma protein binding and drug–drug interactions for siRNA therapeutics
por: Humphreys, Sara C, et al.
Publicado: (2022) -
Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases
por: Sun, Wan, et al.
Publicado: (2020) -
Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis
por: Wei, Xiaohui, et al.
Publicado: (2016) -
Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs
por: Figueiredo, Clara Salles, et al.
Publicado: (2023) -
A review of significant pharmacokinetic drug interactions with antidepressants and their management
por: Hoffelt, Charity, et al.
Publicado: (2016)